Last reviewed · How we verify
AD209
At a glance
| Generic name | AD209 |
|---|---|
| Also known as | AD209 Placebo |
| Sponsor | Addpharma Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase III Study to Evaluate the Efficacy and Safety of AD-209 (PHASE3)
- A Study to Evaluate the Efficacy and Safety of AD-209 (PHASE2)
- Determining the Optimal Dose of AD-209 in Patients With Essential Hypertension (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |